Back
Rise Gold Vs. Axsome Therapeutics Industry Stock Comparison
Sell
46
RYES
Rise Gold
Last Price:
$0.09
Seasonality Move:
-8.51%
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$111.64
Seasonality Move:
19.74%
Sell
46
Rise Gold (RYES)
is a Sell
Is Rise Gold a Buy, Sell or Hold?
-
RYES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYES Stock Price Chart
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $111.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
RYES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 60.84 | Buy |
| Chaikin Money Flow: | 250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 36.05 | Sell |
| Chaikin Money Flow: | 647254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.19 - 127.47) | Sell |
| Bollinger Bands (100): | (89.52 - 121.2) | Buy |
RYES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Buy |
| 20-day SMA: | 0.07 | Buy |
| 50-day SMA: | 0.07 | Buy |
| 200-day SMA: | 0.11 | Sell |
| 8-day EMA: | 0.08 | Buy |
| 20-day EMA: | 0.07 | Buy |
| 50-day EMA: | 0.07 | Buy |
| 200-day EMA: | 0.1 | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.51 | Sell |
| 20-day SMA: | 122.32 | Sell |
| 50-day SMA: | 118.5 | Sell |
| 200-day SMA: | 95.68 | Buy |
| 8-day EMA: | 118.83 | Sell |
| 20-day EMA: | 121.23 | Sell |
| 50-day EMA: | 116.96 | Sell |
| 200-day EMA: | 99.27 | Buy |
Rise Gold Earnings Growth & RYES Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Rise Gold Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||